2024
23 February, 2024
FluoGuide A/S issues warrants to CFO
Copenhagen, Denmark, 23 February 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce...
8 January, 2024
FluoGuide provides strategic update and outlines development plans towards commercialization of FG001
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...
2023
Copenhagen, Denmark, 9 December 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today announces that...
8 December, 2023
FluoGuide raises SEK 12 million through exercise of warrants
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...
Copenhagen, Denmark, 29 November 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its...
13 November, 2023
FluoGuide announces FG001 meets primary endpoint in phase llb trial in aggressive brain cancer
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...
6 November, 2023
FluoGuide confirms positive topline results from phase lla trial of FG001 in head & neck cancer at International Academy of Oral Oncology conference
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...
Copenhagen, Denmark – FluoGuide A/S (OMX: FLUO “FluoGuide” or the “Company”), a pioneer in the cutting-edge...
Copenhagen, Denmark, 8 September 2023 – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the...